[2]    Swarts, F. Bull. Fluorination of organic polyhalides with antimony trifluoride (or zinc and mercury fluorides) in the presence of a trace of a pentavalent antimony salt. Soc. Fr. 1896, 15, 1134-1139.
[3]    Dieter, S. Organic Synthesis-Where Now. Angew. Chem. Int. Ed. 1990, 29, 1320-1367.
[4]    Jean, D. B; Danièle, B. D. Recent advances (1995-2005) in fluorinated pharmaceuticals based on natural products. J. F. Chem. 2006, 127, 992-997.
[5]    (a) Uneyama, K. Organofluorine Chemistry Blackwell: Oxford, 2006. (b) Iseki, K. A Versatile and Straightforward Approach to the 21-Oxidation of β- Substituted and α,β-Unsaturated 20-Oxosteroids. Tetrahedron 1998, 54, 13877-13886.
[6]    Shi, M.; Chen, L. -H.; Li, C. -Q. Chiral Phosphine Lewis Bases Catalyzed Asymmetric aza-Baylis-Hillman Reaction of N-Sulfonated Imines with Activated Olefins. J. Am. Chem. Soc. 2005, 127, 3790-3800.
[7]    Walsh, L. M.; Winn, C. L.; Goodman, J. M. Sulfide–BF3•OEt2 mediated Baylis–Hillman reactions. Tetrahedron Lett. 2002, 43, 8219-8222.
[8]    Chukwuemeka Isanbor, David O’Hagan. Fluorine in medicinal chemistry: A review of anti-cancer agents. J. Fluorine. Chem. 2006, 127, 303-319.
[9]    黄文垣编.中国有机氟化学研究.上海科学技术出版社.1996:203-224, 307-308.
[10]     卿凤翎，邱小龙. 有机氟化学，北京：科学出版社，2007，P159.
[11]    Nakayama, K.; Kawato, H. C.; Inagaki, H.; Nakajima, R.; Kitamura, A.; Someya, K.; Ohta, T. Synthesis and Antifungal Activity of Rhodopeptin Analogues. 2. Modification of the West Amino Acid Moiety. Org. Lett. 2000, 2(7): 977-980.
[12]    Uoto, K.; Ohsuki, S.; Takenoshita H.; Ishiyama T.; Iimura S.; Hirota Y.; Mitsui I.; Terasawa H.; Soga T. Synthesis and structure-activity relationships of novel 2’, 2’-difluoro analogues of docetaxel. Chem. Pharm. Bull. 1997, 45(11): 1793-1804.
[13]    Gouge, V.; Jubault, P.; Quirion, J. Synthesis of difluorinated pseudopeptides using chiral a,a-difluoro-β-amino acids in the Ugi reaction. Tetrahedron Lett. 2004, 45(4): 773–776.
[14]    O’Hagan, D.; B Harper, D., Fluorine-containing natural products[J]. Journal of fluorine chemistry. 1999, 100 (1), 127-133.
[15]    Kim, J., et al., Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer. Cancer Chemotherapy and Pharmacology, 2012. 70(3): p. 381-389.
[16]    Beatriz G,M.,et al., A critical appraisal of lubiprostone in the treatment of chronic constipation in the elderly.Clinical Interventions in Aging 2013:8 191-200.
[17]    Theobald, B., et al., Suppression of Ser/Thr Phosphatase 4 (PP4C/PPP4C) Mimics a Novel Post-Mitotic Action of Fostriecin, Producing Mitotic Slippage Followed by Tetraploid Cell Death. Molecular Cancer Research, 2013. 11(8): p. 845-855.
[18]    Abu Ajaj, K., R. Graeser and F. Kratz, Zosuquidar and an albumin-binding prodrug of zosuquidar reverse multidrug resistance in breast cancer cells of doxorubicin and an albumin-binding prodrug of doxorubicin. Breast Cancer Research and Treatment, 2012. 134(1): p. 117-129.
[19]    Salah H,et al.,Article stability indicating square-wave stripping voltammetric method for determination of Gatifloxacin in pharmaceutical formulation and human blood. J. Braz. Chem. Soc., 2009.10(20), 1790-1799.
[20]    (a) Rozen, S. Elemental Fluorine as a “Legitimate” Reagent for Selective Fluorination of Organic Compounds Acc. Chem. Res. 1988, 21, 307-312. (b) Rozen, S. Elemental Fluorine: Not Only for Fluoroorganic Chemistry. Acc. Chem. Res. 1996, 29, 243-248. 含氟内酯文献综述和参考文献(2):http://www.youerw.com/wenxian/lunwen_31233.html